The Lancet regional health. Europe · 2026
Stigma from healthcare professionals and care-limiting behaviors in individuals with substance use disorders: a mixed-methods study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Luderer Mathias, Stockreiter Dorothea, Binder Annette, Müller Laura, Burger Franca, Stüben Nathalie, Reif Andreas
Аннотация
BACKGROUND: Stigmatization of individuals with substance use disorders (SUDs) by healthcare professionals (HCPs) is a recognized problem, but its direct impact on patient treatment choices has not been systematically quantified. We aimed to provide first robust, quantitative metrics of non-disclosure, treatment avoidance, and treatment discontinuation for any medical treatment directly attributable to HCP stigma and to explore the lived experiences underpinning these behaviors.
METHODS: We conducted a prospective mixed-methods study with 119 adult inpatients with SUDs at a German university hospital (2021-2024). A self-developed questionnaire assessed stigma-related behaviors and their association with self-stigmatization. Qualitative data were analyzed using reflexive thematic analysis (RTA). A person with lived experiences contributed to writing up the manuscript.
FINDINGS: 49.6% (95% CI 40.3-58.9; n = 59/119) reported non-disclosure of substance use, 36.1% (95% CI 27.5-45.5; n = 43/119) avoided necessary medical treatment, and 29.4% (95% CI 21.4-38.5; n = 35/119) discontinued treatment due to stigma. Internalized stigma significantly predicted all three outcomes (aORs 1.055-1.075, p ≤ .001). RTA identified "Institutional Stigma" (addiction as a "moral failing"), "Barriers to Care" (obstacles to respectful treatment), and "Cost of Disclosure" (negative consequences such as hostility after revealing substance use).
INTERPRETATION: Stigma from HCPs is a quantifiable contributor of treatment disengagement, representing a direct threat to patient safety and a major contributor to the SUD treatment gap. These findings underscore the urgent need for evidence-based interventions, including training HCPs across all specialties in non-stigmatizing communication, to improve healthcare engagement for this vulnerable population and narrow the substantial treatment gap.
FUNDING: None.
METHODS: We conducted a prospective mixed-methods study with 119 adult inpatients with SUDs at a German university hospital (2021-2024). A self-developed questionnaire assessed stigma-related behaviors and their association with self-stigmatization. Qualitative data were analyzed using reflexive thematic analysis (RTA). A person with lived experiences contributed to writing up the manuscript.
FINDINGS: 49.6% (95% CI 40.3-58.9; n = 59/119) reported non-disclosure of substance use, 36.1% (95% CI 27.5-45.5; n = 43/119) avoided necessary medical treatment, and 29.4% (95% CI 21.4-38.5; n = 35/119) discontinued treatment due to stigma. Internalized stigma significantly predicted all three outcomes (aORs 1.055-1.075, p ≤ .001). RTA identified "Institutional Stigma" (addiction as a "moral failing"), "Barriers to Care" (obstacles to respectful treatment), and "Cost of Disclosure" (negative consequences such as hostility after revealing substance use).
INTERPRETATION: Stigma from HCPs is a quantifiable contributor of treatment disengagement, representing a direct threat to patient safety and a major contributor to the SUD treatment gap. These findings underscore the urgent need for evidence-based interventions, including training HCPs across all specialties in non-stigmatizing communication, to improve healthcare engagement for this vulnerable population and narrow the substantial treatment gap.
FUNDING: None.